Kejie Chen has nothing to do with Pfizer.
Kejie Chen does not work for Pfizer, but is a China executive of another foreign pharmaceutical company, Bristol-Myers Squibb. A foreign pharmaceutical company executive whose name was unrecognizable died of COVID-19 in his 40s. What he received was not sympathy, but ridicule. Just because some people said that he was a Pfizer executive and "spared no effort to promote Pfizer's new coronavirus specific drug during his lifetime." They also laughed, "Why didn't our own special medicine come in handy?" Some netizens commented, "I recommended it to others, why didn't I keep it?"
In fact, although Chen Kejie has worked for Eli Lilly, Novartis, IQVIA, Bristol-Myers Squibb and other international pharmaceutical companies. But he has never worked for Pfizer, and weighing two to three hundred pounds, it is impossible to say that he does not have underlying diseases.
Introduction to Pfizer
Pfizer was founded in 1849 and has a history of more than 170 years. Headquartered in New York, USA, it is a science-based, innovative and patient-oriented company. leading biopharmaceutical company. Pfizer's goal is to "bring breakthrough innovations to patients that change their lives." Pfizer entered the Chinese market in 1989 and has taken root in China for more than 30 years. Pfizer has become one of the major foreign pharmaceutical companies in China.
Pfizer’s business in China covers more than 300 cities across the country, and has launched high-quality innovative drugs in five major fields in China, including oncology, vaccines, anti-infections, inflammation and immunity, rare diseases and other fields. of prescription drugs and vaccines. Over the years, Pfizer has always been committed to "becoming an important part of China's medical and health system", using global medical resources and cooperating with all sectors of society to actively promote China's health cause.
Reference for the above content: Baidu Encyclopedia—Pfizer Company